|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
| 1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Common Stock Option (2) | $ 8.0794 | 06/01/1997 | 05/31/2006 | Common Stock | 967 | 967 (3) | D | ||||||||
| Common Stock Option (2) | $ 4.789 | 05/31/1998 | 05/30/2007 | Common Stock | 940 | 940 (4) | D | ||||||||
| Common Stock Option (2) | $ 3.8006 | 05/30/1999 | 05/29/2008 | Common Stock | 912 | 912 (5) | D | ||||||||
| Common Stock Option (2) | $ 3.2346 | 05/29/2000 | 05/28/2009 | Common Stock | 912 | 912 (6) | D | ||||||||
| Common Stock Option (2) | $ 4.2049 | 06/03/2001 | 06/02/2010 | Common Stock | 912 | 912 (7) | D | ||||||||
| Common Stock Option (2) | $ 3.3639 | 06/02/2002 | 06/01/2011 | Common Stock | 912 | 912 (8) | D | ||||||||
| Common Stock Option (2) | $ 5.8222 | 06/01/2003 | 05/31/2012 | Common Stock | 912 | 912 (9) | D | ||||||||
| Common Stock Option (2) | $ 5.434 | 05/31/2004 | 05/30/2013 | Common Stock | 912 | 912 (10) | D | ||||||||
| Common Stock Option (2) | $ 12.0971 | 05/29/2005 | 05/28/2014 | Common Stock | 912 | 912 (11) | D | ||||||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
| DAVIS MICHAEL A 4 BALDWIN DRIVE SHARON, MA 020673306 |
X | |||
| By: Joseph A. Cacchioli, as Attorney-In-Fact | 11/03/2004 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | Director compensation in the form of a Restricted Stock Grant. |
| (2) | Options granted under E-Z-EM's Directors and Consultants Stock Option Plan. |
| (3) | This option was previously reported as covering 1,060 shares at an exercise price of $12.4894 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $8.0794 per share and the number of shares was reduced to 967, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. |
| (4) | This option was previously reported as covering 1,030 shares at an exercise price of $7.4029 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $4.7890 per share and the number of shares was reduced to 940, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. |
| (5) | This option was previously reported as covering 1,000 shares at an exercise price of $5.875 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.8006 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. |
| (6) | This option was previously reported as covering 1,000 shares at an exercise price of $5.00 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.2346 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. |
| (7) | This option was previously reported as covering 1,000 shares at an exercise price of $6.50 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $4.2049 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. |
| (8) | This option was previously reported as covering 1,000 shares at an exercise price of $5.20 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.3639 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. |
| (9) | This option was previously reported as covering 1,000 shares at an exercise price of $9.00 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $5.8222 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. |
| (10) | This option was previously reported as covering 1,000 shares at an exercise price of $8.40 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $5.4340 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. |
| (11) | This option was previously reported as covering 1,000 shares at an exercise price of $18.70 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $12.0971 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off. |